Financial report丨PMI's IQOS continues to grow, JT’s revenue reaches $4.5 billion, and Altria’s net profit increases by 37%

Recently, Philip Morris International released its first-quarter financial report: HNB shipments reached 24.8 billion in the first quarter, accounting for 31.2% of revenue.

Image source: Philip Morris International official website

Philip Morris International’s first-quarter adjusted net income was $7.746 billion, an increase of 9% from last year; adjusted operating income was $3.34 billion, an increase of 8.3%. Adjusted operating income margin was 43.1%.

Image source: Philip Morris International official website

From the perspective of sales volume, IQOS atomized bombs have accounted for 14.34% of the company’s total shipments (including traditional cigarettes) (a year-on-year increase of 1.35%). Among them, the sales revenue of IQOS equipment in the first quarter of 2022 is about 126 million US dollars, accounting for about 6% of the revenue of the harm reduction product segment, mainly due to the popularity of ILUMA.

As of the first quarter of 2022, the number of IQOS users (excluding Russia and Ukraine) has reached 17.9 million, an increase of more than 1 million from the end of 2021, of which the number of users who have completely converted into IQOS consumption (ie stop using traditional cigarettes) has reached 12.7 million (71% retention rate); the comprehensive market share of IQOS atomizers in 71 countries and regions around the world (except the United States) reached 7.5%, a year-on-year increase of 1.1%.

CEOJacek Olczak says: The IQOS business continued to grow in the quarter, the total number of IQOS users increased by more than 1 million sequentially, and ILUMA achieved outstanding performance in the initial launch market. Strong top- and bottom-line growth is expected this year on an estimated adjusted basis.

Japan Tobacco

Japan Tobacco (JT) has released results for the first quarter of 2022, with revenue reaching $4.5 billion, an increase of 6.2% compared to last year

Image source: Japan Tobacco’s official website

JT’s first-quarter revenue rose 6.2% to $4.5 billion. Adjusted operating profit rose 4.5% to $1.37 billion, while corporate profit rose 9.1% to $955 million and free cash flow increased from $214 million to $141 million.

In the first quarter of 2022, sales of harm reduction products increased by 16%, and in terms of HTS, Ploom X’s Japanese market share increased to 7.2%.

Image source: Japan Tobacco’s official website

JT Group President and CEO Shiyue Zhengdao said: “In the first quarter, JT Group achieved strong results, with adjusted operating profit increasing by 4.5% at constant exchange rates. But there are still some uncertainties, such as rapidly evolving operating costs and very volatile inflation. As of the first quarter, the Group has not revised its full-year plan for the time being.

Altria

Altria’s net income in the first quarter reached $5.892 billion, a decrease of 2.4% compared to 2021, operating profit was $2.884 billion, a year-on-year increase of 7.2%, and net profit was $1.959 billion, a year-on-year increase of 37.57%.

Image source: Altria official website

Regarding the investment in JUUL, Altria stated: JUUL’s business has not been significantly affected by macroeconomic risks and geopolitical instability, but the impact of rising U.S. interest rates has led to an increase in the discount rate, which has a significant impact on the Group’s performance on March 31, 2022. The fair value of the investment in JUUL was adversely affected. The Group will continue to pay attention to JUUL’s business and incorporate recent supply chain constraints, parts shortages and inflation into JUUL’s quarterly quantitative valuation. As of March 31, 2022, the estimated fair value of Altria’s investment in JUUL was $1.6 billion.

Altria CEO Billy Gifford said: “We have had a strong year and believe the business is on track to complete the full year plan. Our tobacco business has performed well in a challenging macroeconomic environment and continues to progress towards our vision.

Smoore

Smoore’s revenue in the first quarter was 526 million yuan, down 55.3% year-on-year. Smoore said that the impact of the epidemic will be temporary and will not affect production and plans throughout the year. At the same time, the R&D expenditure in the first quarter increased more than the previous year, which helped the Group maintain its technological leadership in the field of atomization, broaden the application fields of atomization technology, and enhance the long-term competitiveness of the Group.